Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis

Autor: Bütikofer L, Varisco PA, Distler O, Kowal-Bielecka O, Allanore Y, Riemekasten G, Villiger PM, Adler S, Avouac J, Walker UA, Guiducci S, Airò P, Hachulla E, Valentini G, Carreira PE, Cozzi F, Gurman AB, Braun-Moscovici Y, Damjanov N, Ananieva LP, Scorza R, Jimenez S, Busquets J, Li M, Müller-Ladner U, Maurer B, Tyndall A, Lapadula G, Iannone F, Becvar R, Sierakowsky S, Bielecka OK, Cutolo M, Sulli A, Cuomo G, Vettori S, Rednic S, Nicoara I, Vlachoyiannopoulos P, Montecucco C, Caporali R, Novak S, Czirják L, Varju C, Chizzolini C, Kucharz EJ, Kotulska A, Kopec-Medrek M, Widuchowska M, Rozman B, Mallia C, Coleiro B, Gabrielli A, Farge D, Hij A, Hesselstrand R, Scheja A, Wollheim F, Martinovic D, Govoni M, Monaco AL, Hunzelmann N, Pellerito R, Bambara LM, Caramaschi P, Black C, Denton C, Henes J, Santamaria VO, Heitmann S, Krasowska D, Seidel M, Oleszowsky M, Burkhardt H, Himsel A, Salvador MJ, Stamenkovic B, Stankovic A, Tikly M, Starovoytova MN, Engelhart M, Strauss G, Nielsen H, Damgaard K, Szücs G, Mendoza AZ, de la Puente Buijdos C, Sifuentes Giraldo WA, Midtvedt Ø, Garen T, Launay D, Valesini G, Riccieri V, Ionescu RM, Opris D, Groseanu L, Wigley FM, Mihai CM, Cornateanu RS, Ionitescu R, Gherghe AM, Gorga M, Dobrota R, Bojinca M, Schett G, Distler JHW, Meroni P, Zeni S, Mouthon L, De Keyser F, Smith V, Cantatore FP, Corrado A, Ullman S, Iversen L, Pozzi MR, Eyerich K, Hein R, Knott E, Szechinski J, Wiland P, Szmyrka-Kaczmarek M, Sokolik R, Morgiel E, Krummel-Lorenz B, Saar P, Aringer M, Günther C, Anic B, Baresic M, Mayer M, Radominski SC, de Souza Müller C, Azevedo VF, Agachi S, Groppa L, Chiaburu L, Russu E, Zenone T, Stebbings S, Highton J, Stamp L, Chapman P, Baron M, O'Donnell J, Solanki K, Doube A, Veale D, O'Rourke M, Loyo E, Rosato E, Pisarri S, Tanaseanu CM, Popescu M, Dumitrascu A, Tiglea I, Chirieac R, Ancuta C, Furst DE, Kafaja S, de la Peña Lefebvre PG, Rubio SR, Exposito MV, Sibilia J, Chatelus E, Gottenberg JE, Chifflot H, Litinsky I, Venalis A, Butrimiene I, Venalis P, Rugiene R, Karpec D, Kerzberg E, Montoya F, Cosentino V, Castellvi I.

Publikováno v: Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-9 (2020)
ARTHRITIS RESEARCH & THERAPY
Arthritis Research & Therapy
Bütikofer, Lukas; Varisco, Pierre A; Distler, O; Kowal-Bielecka, O; Allanore, Y; Riemekasten, G; Villiger, P.M.; Adler, S. (2020). ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. Arthritis research & therapy, 22(1), p. 59. BioMed Central 10.1186/s13075-020-2141-2

Objectives To investigate the effect of ACE inhibitors (ACEi) on the incidence of scleroderma renal crisis (SRC) when given prior to SRC in the prospectively collected cohort from the European Scleroderma Trial and Research Group (EUSTAR). Methods SS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fccfad8e2e289f92d9e88cb4fd4b694a
http://link.springer.com/article/10.1186/s13075-020-2141-2

Umsetzung von Biosicherheitsmassnahmen durch Klauenpfleger in der Schweiz. (German)

Autor: Bayer, M., Strauss, G., Syring, C., Ruiters, M., Becker, J., Steiner, A.

Publikováno v: Schweizer Archiv für Tierheilkunde; May2023, Vol. 165 Issue 5, p307-320, 14p

Direct mutagen risk assessment : The development of the Strauss-Albertini test and other methods to measure immunologic and genetic responses to mutagens

Autor: Strauss, G. H. S.

Externí odkaz: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.349169

Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming

Autor: Hirschberger, S., Strauß, G., Effinger, D., Marstaller, X., Ferstl, A., Müller, M.B., Wu, T., Hübner, M., Rahmel, T., Mascolo, H., Exner, N., Hess-Rieger, J., Kreth, F.W., Unger, K., Kreth, S.

Publikováno v: EMBO Molecular Medicine
EMBO Mol. Med.:e14323 (2021)

Very‐low‐carbohydrate diet triggers the endogenous production of ketone bodies as alternative energy substrates. There are as yet unproven assumptions that ketone bodies positively affect human immunity. We have investigated this topic in an in v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::882bfb6e5eb3005aecd8295f2fd1158c
https://pubmed.ncbi.nlm.nih.gov/34151532